These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pituitary-adrenocortical stimulation in the aged as reflected in levels of plasma cortisol and compound S. Blichert-Toft M; Blichert-Toft B; Jensen HK Acta Chir Scand; 1970; 136(8):665-70. PubMed ID: 4325663 [No Abstract] [Full Text] [Related]
7. Comparison of the hypothalamic-pituitary-adrenal axis susceptibility upon single-dose i.m. depot versus long-acting i.v. triamcinolone acetonide therapy: a direct pharmacokinetic correlation. Abraham G; Demiraj F; Ungemach FR J Endocrinol; 2006 Nov; 191(2):491-6. PubMed ID: 17088419 [TBL] [Abstract][Full Text] [Related]
9. Adrenocortical suppression by topically applied corticosteroids in healthy dogs. Zenoble RD; Kemppainen RJ J Am Vet Med Assoc; 1987 Sep; 191(6):685-8. PubMed ID: 2824410 [TBL] [Abstract][Full Text] [Related]
10. [Inhibition of the adrenal gland function by acetylated derivatives of adrenocorticotropic hormone]. Dil'man VM; Prokudina EA; Bulovskaia LN; Konstantinov VL; Tugunov SS Biull Eksp Biol Med; 1970 Mar; 69(3):69-71. PubMed ID: 4323991 [No Abstract] [Full Text] [Related]
11. [Long-term therapy using depot-corticoids and the adrenal cortex system]. Lange R Med Welt; 1971 Nov; 48(71):1930-2. PubMed ID: 5002421 [No Abstract] [Full Text] [Related]
12. The depot-form of glucocorticoid decreases cortisol but not ACTH and beta-endorphin levels in human plasma. Lypka A; Lazowski J; Szczudlik A; Wasek Z Horm Metab Res; 1983; 15(2):104-6. PubMed ID: 6298088 [No Abstract] [Full Text] [Related]
13. [Persistance of the adrenocortical circadian rhythm in the course of submaximal corticoid inhibition obtained with a preparation with delayed absorption]. Ceresa F; Angeli A; Boccuzzi G; Perotti L; Molino G Folia Endocrinol; 1968 Feb; 21(1):1-17. PubMed ID: 4301491 [No Abstract] [Full Text] [Related]
14. [Comparative study on intramuscular and intraarticular administration of the depot steroid Triamcinolone acetonide]. Rausch-Stroomann JG; Petry R; Brandt T; Thomas E Arzneimittelforschung; 1971 Jun; 21(6):836-40. PubMed ID: 5109272 [No Abstract] [Full Text] [Related]
16. Corticosteroid-induced suppression of the hypothalamo-pituitary-adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis. Jasani MK; Boyle JA; Greig WR; Dalakos TG; Browning MC; Thompson A; Buchanan WW Q J Med; 1967 Jul; 36(143):261-76. PubMed ID: 6049762 [No Abstract] [Full Text] [Related]
17. Pituitary-adrenal function following topical triamcinolone acetonide and occlusion. Taylor KS; Malkinson FD; Gak C Arch Dermatol; 1965 Aug; 92(2):174-7. PubMed ID: 11850923 [TBL] [Abstract][Full Text] [Related]
18. [Clinical-experimental studies on the inhibitory effect of various corticoids]. Hochheuser W; Gerb A; Müller-Bardorff M; Thiele H Dtsch Med Wochenschr; 1969 Nov; 94(48):2488-94. PubMed ID: 4310869 [No Abstract] [Full Text] [Related]
19. Effects of steroids and ACTH on pyruvate and acetate metabolism by the sheep adrenal cortex in vitro. Gand JH; Shaefer J Endocrinology; 1968 May; 82(5):995-1000. PubMed ID: 4297461 [No Abstract] [Full Text] [Related]
20. [Pharmacodynamic evaluation of synthetic prolonged-action ACTH on the adrenal function of patients with hypothalamo-pituitary pathology. Comparative study of synthetic ACTH and extra-delayed-action gel]. Artese R; De Laszlo MH; Molocznik I; Varela J; Guitelman A; Brussino M; Dickmann GH; Montes ME Prensa Med Argent; 1971 Jan; 57(46):2088-97. PubMed ID: 4326359 [No Abstract] [Full Text] [Related] [Next] [New Search]